P01 UHREG

From LipidomicsWiki

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
|myCountry=Germany
|myCountry=Germany
|myBenefitnr=P01
|myBenefitnr=P01
-
|myAbout=The Regensburg Diabetes Prediction and Prevention Study (REDEPPS), is an interdisciplinary resarch and biobanking project involving clinical and theoretical institutions at the university, local teaching hospitals and also hosts the “Fraunhofer Project Group on Disease and Toxicoproteomics of Aging Disorders” lead by Prof. Borlak and [[User:Gerd_Schmitz|Prof. Gerd Schmitz]].
+
|myAbout=The Institute for Clinical Chemistry and Laboratory Medicine is part of the University Hospital Regensburg. It combines basic research with clinical association studies thus enabling a rapid transfer of newly identified candidate biomarkers from basic science to clinical diagnostics. Furthermore, UHREG has long-term experience in biobanking (EU-FP6 SSA: Danubian Biobank Project) and pre- and post-analytical procedures for sensible biological materials.
|myContribution=[[User:Gerd_Schmitz|Prof. MD Gerd Schmitz]] is the coordinator of the project and member of the MT.  
|myContribution=[[User:Gerd_Schmitz|Prof. MD Gerd Schmitz]] is the coordinator of the project and member of the MT.  
P01 provides strong expertise in transcriptomics, mass spectrometry, flow cytometry and imaging combined with chemometry and bioinformatics. Prof. Borlak (Fraunhofer Project Group Hannover/Regensburg) is responsible for the WP6 contributions from Regensburg. The colleagues from Internal Medicine and the Liver Center support the project with patient materials and as members of the REDEPPS consortium with patient cohorts for [[WP4]] and [[WP5]]. Prof. Kalbitzer and Prof. Lang support the groups in Regensburg with NMR-analysis,
P01 provides strong expertise in transcriptomics, mass spectrometry, flow cytometry and imaging combined with chemometry and bioinformatics. Prof. Borlak (Fraunhofer Project Group Hannover/Regensburg) is responsible for the WP6 contributions from Regensburg. The colleagues from Internal Medicine and the Liver Center support the project with patient materials and as members of the REDEPPS consortium with patient cohorts for [[WP4]] and [[WP5]]. Prof. Kalbitzer and Prof. Lang support the groups in Regensburg with NMR-analysis,

Revision as of 13:04, 18 February 2010

InstitutionInstitute for Clinical Chemistry and Laboratory Medicine
Principal investigator {{{myPrincipal_investigator}}}
Country Germany
Beneficiary NumberP01
About usThe Institute for Clinical Chemistry and Laboratory Medicine is part of the University Hospital Regensburg. It combines basic research with clinical association studies thus enabling a rapid transfer of newly identified candidate biomarkers from basic science to clinical diagnostics. Furthermore, UHREG has long-term experience in biobanking (EU-FP6 SSA: Danubian Biobank Project) and pre- and post-analytical procedures for sensible biological materials.
ContributionsProf. MD Gerd Schmitz is the coordinator of the project and member of the MT.

P01 provides strong expertise in transcriptomics, mass spectrometry, flow cytometry and imaging combined with chemometry and bioinformatics. Prof. Borlak (Fraunhofer Project Group Hannover/Regensburg) is responsible for the WP6 contributions from Regensburg. The colleagues from Internal Medicine and the Liver Center support the project with patient materials and as members of the REDEPPS consortium with patient cohorts for WP4 and WP5. Prof. Kalbitzer and Prof. Lang support the groups in Regensburg with NMR-analysis,

molecular modelling and bioinformatics.
Member of TaskforcesTask Force I, Task Force II, Task Force III, Task Force IV, Task Force VI,Task Force VII, Task Force VIII, Task Force IX
Member of WorkpackagesWP1, WP2, WP4, WP5, WP6, WP7, WP8

Back to List of Beneficiaries


Personal tools
Create a book